EIF4A1 and breast cancer: For instance, eIF4A inhibitors (eIF4Ais), which are derivatives of a class of natural products called the flavaglines, were shown to have strong anti-tumour actions against BC/PC cells both in vitro and in vivo [158,159,160,161,162,163,164,165].